原著 |
|
|
|
|
癫痫鼠外周血磷酸化S6蛋白检测及意义 |
范苗1( ),董淑敏1,邹心怡1,郑博远1,黄玉润1,王健达2,*( ),曾玲晖1,*( ) |
1. 浙江大学城市学院医学院, 浙江 杭州 310015 2. 浙江大学医学院附属第二医院儿科, 浙江 杭州 310009 |
|
Correlation of phosphorylated S6 protein expression in blood and brain tissue in mice and rats with kainic acid-induced seizure |
FAN Miao1( ),DONG Shuminin1,ZOU Xinyi1,ZHENG Boyuan1,HUANG Yurun1,WANG Jianda2,*( ),ZENG Linghui1,*( ) |
1. School of Medicine, Zhejiang University City College, Hangzhou 310015, China 2. Department of Paediatrics, the Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China |
引用本文:
范苗, 董淑敏, 邹心怡, 郑博远, 黄玉润, 王健达, 曾玲晖. 癫痫鼠外周血磷酸化S6蛋白检测及意义[J]. 浙江大学学报(医学版), 2019, 48(3): 303-309.
FAN Miao, DONG Shuminin, ZOU Xinyi, ZHENG Boyuan, HUANG Yurun, WANG Jianda, ZENG Linghui. Correlation of phosphorylated S6 protein expression in blood and brain tissue in mice and rats with kainic acid-induced seizure. J Zhejiang Univ (Med Sci), 2019, 48(3): 303-309.
链接本文:
http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2019.06.11
或
http://www.zjujournals.com/med/CN/Y2019/V48/I3/303
|
1 |
PERL A E , KASNER M T , SHANK D et al. Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy[J]. Clin Cancer Res, 2012, 18 (6): 1716- 1725
doi: 10.1158/1078-0432.CCR-11-2346
|
2 |
LEE D Y . Roles of mTOR signaling in brain development[J]. Exp Neurobiol, 2015, 24 (3): 177- 185
doi: 10.5607/en.2015.24.3.177
|
3 |
HUANG X , MCMAHON J , YANG J et al. Rapamycin down-regulates KCC2 expression and increases seizure susceptibility to convulsants in immature rats[J]. Neuroscience, 2012, 219:33- 47
doi: 10.1016/j.neuroscience.2012.05.003
|
4 |
LOZOVAYA N , GATAULLINA S , TSINTSADZE T et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model[J]. Nat Commun, 2014, 5:4563
doi: 10.1038/ncomms5563
|
5 |
MANNING B D . Game of TOR-the target of rapamycin rules four kingdoms[J]. N Engl J Med, 2017, 377 (13): 1297- 1299
doi: 10.1056/NEJMcibr1709384
|
6 |
CITRARO R , LEO A , CONSTANTI A et al. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis[J]. Pharmacol Res, 2016, 107:333- 343
doi: 10.1016/j.phrs.2016.03.039
|
7 |
SUN A , LI C , CHEN R et al. GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells[J]. Prostate, 2016, 76 (2): 172- 183
doi: 10.1002/pros.23106
|
8 |
MEIKLE L , POLLIZZI K , EGNOR A et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors:effects on mTORC1 and Akt signaling lead to improved survival and function[J]. J Neurosci, 2008, 28 (21): 5422- 5432
doi: 10.1523/JNEUROSCI.0955-08.2008
|
9 |
ZENG L H , RENSING N R , ZHANG B et al. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex[J]. Hum Mol Genet, 2011, 20 (3): 445- 454
doi: 10.1093/hmg/ddq491
|
10 |
MUNCY J , BUTLER I J , Koenig M K . Rapamycin reduces seizure frequency in tuberous sclerosis complex[J]. J Child Neurol, 2009, 24 (4): 477
doi: 10.1177/0883073808324535
|
11 |
吕合作, 李柏青 . 胞内磷酸化蛋白酪氨酸激酶的流式细胞术检测[J]. 蚌埠医学院学报, 2005, 30 (2): 95- 97 LYU Hezuo , LI Baiqing . Detection of intracellular phosphorylated protein tyrosine kinases by flow cytometry[J]. Journal of Bengbu Medical College, 2005, 30 (2): 95- 97
doi: 10.3969/j.issn.1000-2200.2005.02.001
|
12 |
WALKER L E , FRIGERIO F , RAVIZZA T et al. Molecular isoforms of high-mobility group box 1 are mechanistic biomarkers for epilepsy[J]. J Clin Invest, 2017, 127 (6): 2118- 2132
doi: 10.1172/JCI92001
|
13 |
CHEN S , ATKINS C M , LIU C L et al. Alterations in mammalian target of rapamycin signaling pathways after traumatic brain injury[J]. J Cereb Blood Flow Metab, 2007, 27 (5): 939- 949
doi: 10.1038/sj.jcbfm.9600393
|
14 |
ZENG L H , XU L , GUTMANN D H et al. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex[J]. Ann Neurol, 2008, 63 (4): 444- 453
doi: 10.1002/ana.21331
|
15 |
ZENG L H , RENSING N R , ZHANG B et al. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex[J]. Hum Mol Genet, 2011, 20 (3): 445- 454
doi: 10.1093/hmg/ddq491
|
16 |
MCMAHON J , HUANG X , YANG J et al. Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis[J]. J Neurosci, 2012, 32 (45): 15704- 15714
doi: 10.1523/JNEUROSCI.2392-12.2012
|
17 |
LEE J H , HUYNH M , SILHAVY J L et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly[J]. Nat Genet, 2012, 44 (8): 941- 945
doi: 10.1038/ng.2329
|
18 |
LIM J S , KIM W I , KANG H C et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type Ⅱ leading to intractable epilepsy[J]. Nat Med, 2015, 21 (4): 395- 400
doi: 10.1038/nm.3824
|
19 |
ORLOVA K A , PARKER W E , HEUER G G et al. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice[J]. J Clin Invest, 2010, 120 (5): 1591- 1602
doi: 10.1172/JCI41592
|
20 |
BALDASSARI S , LICCHETTA L , TINUPER P et al. GATOR1 complex:the common genetic actor in focal epilepsies[J]. J Med Genet, 2016, 53 (8): 503- 510
doi: 10.1136/jmedgenet-2016-103883
|
21 |
ZHANG Y X , SHEN C H , GUO Y et al. BRAF V600E mutation in epilepsy-associated glioneuronal tumors:Prevalence and correlation with clinical features in a Chinese population[J]. Seizure, 2017, 45:102- 106
doi: 10.1016/j.seizure.2016.12.004
|
22 |
LI C , TAKAHASHI C , ZHANG L et al. Development of a robust flow cytometry-based pharmacodynamic assay to detect phospho-protein signals for phosphatidylinositol 3-kinase inhibitors in multiple myeloma[J]. J Transl Med, 2013, 11:76
doi: 10.1186/1479-5876-11-76
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|